The United States Food and Drug Administration granted emergency use authorization to a 15-minute COVID-19 test produced by Abbott Laboratories (NYSE: ABT) on Wednesday.What Happened:The BinaxNOW COVID-19 test, priced at $5, is capable of delivering test results without laboratory instrumentation and comes with an accompanying smartphone app that patients can use to display their results at no cost, Abbott said in a statement.The FDA granted the EUA with a caveat that negative results of the test don’t rule out infection with SARS-COV-2 and the test should not be used as the sole basis for treatment.The drugmaker said it will start …read more
Source:: Yahoo Finance
